admin

Monkeypox in Europe

Declaración EACS viernes, 20 de mayo de 2022 Reino Unido, España y Portugal están notificando casos de viruela del simio entre, pero no exclusivamente, hombres que tienen sexo con hombres (HSH). Se están notificando casos confirmados aislados o casos en investigación en Suecia, Italia, Bélgica, EE. UU. y Canadá. Muchos de estos casos no están relacionados con […]

Monkeypox in Europe Read More »

African scientists baffled by monkeypox cases in Europe and the United States

By Maria Cheng, London (AP) – Scientists who have monitored numerous monkeypox outbreaks in Africa say they are baffled by the disease's recent spread to Europe and North America. Until now, cases of this smallpox-related illness had been found only among people linked to Central and West Africa.

African scientists baffled by monkeypox cases in Europe and the United States Read More »

A new pandemic danger? Pretending it's over as the number of cases increases.

Damian McNamara, MA Just because many people seem more than ready to put the COVID-19 pandemic behind them doesn't mean it's truly over. In fact, case numbers are rising again, with approximately 95,000 new infections reported in the United States each day, and hospitalizations have also increased by 20%. It's yet another reminder of

New pandemic danger? Pretending it's over as the number of cases rises. Read More »

The FDA has lifted the clinical suspension of investigational lenacapavir for the treatment of HIV and pre-exposure prophylaxis. All clinical trials evaluating injectable lenacapavir can now resume.

This week, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) reinstated the company's Investigational New Drug (IND) designation to study injectable lenacapavir for the treatment of HIV and pre-exposure prophylaxis (PrEP). The FDA had previously suspended lenacapavir in borosilicate vials due to issues.

The FDA has lifted the clinical suspension of investigational lenacapavir for the treatment of HIV and pre-exposure prophylaxis. All clinical trials evaluating injectable lenacapavir can now resume. Read More »

Good vibes: The transition from sex toy to medical device

PorCharles Bankhead, Senior Editor, MedPage Today  Beneficios de los vibradores en la incontinencia urinaria, la vulvodinia y la disfunción sexual en la mujer Los estudios médicos formales de los vibradores han revelado efectos positivos en múltiples resultados sexuales y urinarios en las mujeres, según mostró una revisión de la literatura publicada. Aunque su número es

Good vibes: The transition from sex toy to medical device Read More »

Paxlovid: Key points for proper use against COVID-19

By Olga Delgado, president of the Spanish Society of Hospital Pharmacy (SEFH). Paxlovid is the combination of nirmatrelvir and ritonavir (a new therapeutic option for the treatment of SARS-CoV-2 infection, which adds to the options we had until now, which is always good news for patients, professionals, and the healthcare system). Nirmatrelvir is an antiviral.

Paxlovid: Key points for proper use against COVID-19 Read More »

The unknowns in long COVID: treatments, variants, and vaccination

Disseminating protocols and guidelines for long COVID among healthcare professionals is essential for the proper management of patients. By Miguel Ramudo. Although current scientific knowledge about long COVID is very limited, various guidelines and protocols have been developed with measures to care for patients affected by this disease. Thanks to increasingly advanced research, we are able to better understand and manage these conditions.

The unknowns in long COVID: treatments, variants, and vaccination Read More »